Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Sativex

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Sativex is an endocannabinoid system modulator principally containing Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD). During… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 2
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Background: Open-label studies are not ideal for providing robust evidence for long-term maintenance of efficacy of medicines… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Background:  Spasticity is a disabling complication of multiple sclerosis, affecting many patients with the condition. We report… Expand
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Abstract Background: Muscle spasticity is common in multiple sclerosis (MS), occurring in more than 60% of patients. Objective… Expand
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Background: Bladder dysfunction is a common feature of multiple sclerosis (MS). Objective: In this study we aimed to assess the… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Objective: To determine the efficacy of Sativex (USAN: nabiximols) in the alleviation of spasticity in people with multiple… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
2009
Highly Cited
2009
OBJECTIVE To assess the efficacy of Sativex, a cannabis-based medicinal extract, as adjuvant treatment in painful diabetic… Expand
  • table 1
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Abstract Cannabinoids are known to have analgesic properties. We evaluated the effect of oro‐mucosal sativex, (THC: CBD), an… Expand
  • figure 1
  • table 2
  • figure 2
  • figure 3
  • table 3
Is this relevant?
Highly Cited
2006
Highly Cited
2006
OBJECTIVES To assess the efficacy of a cannabis-based medicine (CBM) in the treatment of pain due to rheumatoid arthritis (RA… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
The objective was to determine whether a cannabis-based medicinal extract (CBME) benefits a range of symptoms due to multiple… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?